Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study
| Image |  |
|---|---|
| Description | scientific article published on 13 January 2016 |
| Author/s |
author: Alfons A den Broeder |
| Publication date | January 13, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |